1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
EGF Theramed Health Corp.

EGF Theramed Health Corp.

TMED.CN
EGF Theramed Health Corp.CA flagCanadian Securities Exchange
0.07
CAD
-0.01
- -
813,167.00Market Cap
EGF Theramed Health Corp.
TMED.CN
(Canadian Securities Exchange)

Recent

price

0.07

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
- -
- -
- -
4.92
-97.29
- -
- -
- -
- -
-0.05
-0.63
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
-15
-280.79
- -
- -
- -
- -
-0.04
-0.46
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
30.86
-120.44
- -
- -
- -
- -
-0.18
-2.31
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
-15.95
-648.66
- -
- -
- -
- -
-0.07
-1.08
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
21
2
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
-37
-1
-15
-20
-1
-1
-1
- -
-3
-3
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
-1
-1
-1
-3
-2
-1
-2
-2
-1
-2
-3
-3
-6
Working Capital
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
1
1
- -
- -
- -
LT Debt
- -
- -
1
1
3
3
-3
-2
- -
-2
-1
-2
-2
-3
-6
-6
Total Equity
- -
- -
- -
- -
-6.11
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
19.97
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
12
12
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
6
6
6
Payables & Accruals
1
1
2
ST Debt
2
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-101.49%
37.25%
118.64%
Free Cash Flow
26.9%
-56.33%
-122.08%
Net Income, GAAP
1,271.67%
184.73%
1,090.76%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Accelera Innovations, Inc (ACNV)
Mach7 Technologies Limited (M7T.AX)
Imaging Biometrics Ltd. (IBAI.L)
Mednow Inc. (MDNWF)
Feedback plc (FDBK.L)
FINDEX Inc. (3649.T)
Business
EGF Theramed Health Corp. (CSE:TMED, OTC:EVAHF) is a Canada-based early-stage development company that develops products, technologies, and diagnostic tools focused on personalized medical care; natural health and wellness products; and psychedelic drugs for treating mental health conditions including treatment-resistant depression, anxiety, post-traumatic stress disorder (PTSD), and depression. The company also explores therapeutic areas such as weight loss, skincare, and heart disease through botanical extracts, extract formulations, and medical monitoring device technologies. Founded in 2011 and headquartered in Vancouver, British Columbia, EGF Theramed operates primarily in Canada with assets held through subsidiaries and joint ventures. In recent developments, the company closed a joint venture by acquiring a 30% to 40% interest in biosynthesis firm Pharmadelic Labs Inc., which signed a laboratory services agreement to advance psychedelic research and production; it further pursues collaborations for medical technology, equipment protocols, and laboratory procedures.